Louise Warren

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

Frances Humby, Patrick Durez, Maya H Buch et al. · The Lancet · 2021 · 315 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

Felice Rivellese, Anna E. A. Surace, Katriona Goldmann et al. · Nature Medicine · 2022 · 279 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Confirmation of the association of the C4B null allelle in autism

Dennis Odell, Alma Maciulis, Adele Cutler et al. · Human Immunology · 2005 · 111 citations

Life Sciences, Genetics, Immunology +6

Reducing Antibiotic Prescribing in Primary Care for Respiratory Illness

Matthew P. Kronman, Jeffrey S. Gerber, Robert W. Grundmeier et al. · PEDIATRICS · 2020 · 101 citations · Full text

Pharmacy, Pediatrics, Pharmacy Practice +15

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials

Felice Rivellese, Alessandra Nerviani, Giovanni Giorli et al. · The Lancet Rheumatology · 2023 · 68 citations · Full text

Medicine, Immunology, Pathobiology +15